May 9, 2017 -
BIO-key International will issue its Q1 2017 results post-market on May 15, and management will host a conference call to review the results on May 16 at 10:00 am EDT.
Chairman and CEO Mike DePasquale, CFO Cecilia Welch and COO Barbara Rivera will be participating on the call.
The company recently raised $1 million through the sale of common stock priced at $3.60 per share through a private placement with an existing investor and member of its Board.
At the time, Bio-Key CEO Michael DePasquale said, “We are grateful for the continued strategic and financial support of our investors as we seek to position BIO-key for listing on the Nasdaq Capital Market. The funding initiatives – both priced well above the recent trading prices of BIO-key shares – are intended to support our ongoing growth in the business and Nasdaq uplisting plan.